Trial Profile
Cetuximab plus radiotherapy in patients with head and neck squamous cell carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2016
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 05 Dec 2016 New trial record
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress